Dori vositalarining innovatsion kashfiyoti va nanotexnologiya inqilob qildi
dori samaradorligini oshirish, nojo'ya ta'sirlarni kamaytirish va maqsadli foydalanish imkonini berish orqali farmatsevtika sanoati.
dori yetkazib berish. Nanotexnologiyaning farmatsevtikaga integratsiyalashuvi rivojlanish imkonini beradi
nano-asosli dori tashuvchilarning bioavailability va terapevtik natijalarini yaxshilash. Bu yondashuv
surunkali kasalliklarni, shu jumladan saraton, neyrodegenerativ kasalliklarni davolashda muhim salohiyatni ko'rsatdi
buzilishlar, yuqumli kasalliklar. Bundan tashqari, nanomika sohasidagi yutuqlar bunga hissa qo'shadi
aniq va samarali davolanishni ta'minlaydigan shaxsiylashtirilgan tibbiyot. Ushbu maqola so'nggi paytlarni o'rganadi
dori vositalarining innovatsion kashfiyotidagi ishlanmalar va kelajakni shakllantirishda nanotexnologiyaning roli
farmatsevtika mahsulotlari.
Dori vositalarining innovatsion kashfiyoti va nanotexnologiya inqilob qildi
dori samaradorligini oshirish, nojo'ya ta'sirlarni kamaytirish va maqsadli foydalanish imkonini berish orqali farmatsevtika sanoati.
dori yetkazib berish. Nanotexnologiyaning farmatsevtikaga integratsiyalashuvi rivojlanish imkonini beradi
nano-asosli dori tashuvchilarning bioavailability va terapevtik natijalarini yaxshilash. Bu yondashuv
surunkali kasalliklarni, shu jumladan saraton, neyrodegenerativ kasalliklarni davolashda muhim salohiyatni ko'rsatdi
buzilishlar, yuqumli kasalliklar. Bundan tashqari, nanomika sohasidagi yutuqlar bunga hissa qo'shadi
aniq va samarali davolanishni ta'minlaydigan shaxsiylashtirilgan tibbiyot. Ushbu maqola so'nggi paytlarni o'rganadi
dori vositalarining innovatsion kashfiyotidagi ishlanmalar va kelajakni shakllantirishda nanotexnologiyaning roli
farmatsevtika mahsulotlari.
Allen, T. M., & Cullis, P. R. (2013). Liposomal drug delivery systems: from concept to clinical applications. Advanced Drug Delivery Reviews, 65(1), 36-48.
Ferrari, M. (2005). Cancer nanotechnology: opportunities and challenges. Nature Reviews Cancer, 5(3), 161-171.
Duncan, R., & Gaspar, R. (2011). Nanomedicine(s) under the microscope. Molecular Pharmaceutics, 8(6), 2101-2141.
Zhang, L., Gu, F. X., Chan, J. M., Wang, A. Z., Langer, R. S., & Farokhzad, O. C. (2008). Nanoparticles in medicine: therapeutic applications and developments. Clinical Pharmacology & Therapeutics, 83(5), 761-769.
Torchilin, V. P. (2014). Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nature Reviews Drug Discovery, 13(11), 813-827.
Park, K. (2017). The beginning of the nanomedicine era. Journal of Controlled Release, 303, 211-221.
Wang, X., Yang, L., Chen, Z. G., & Shin, D. M. (2008). Application of nanotechnology in cancer therapy and imaging. CA: A Cancer Journal for Clinicians, 58(2), 97-110.
Whitesides, G. M. (2005). Nanotechnology: preparing for the future. Science, 310(5751), 61-63.
Wang, A. Z., Langer, R., & Farokhzad, O. C. (2012). Nanoparticle delivery of cancer drugs. Annual Review of Medicine, 63, 185-198.